CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $530,724 | +21.7% | 76,144 | +37.6% | 0.02% | +21.4% |
| Q3 2022 | $436,000 | -41.6% | 55,320 | +2.8% | 0.01% | -36.4% |
| Q2 2022 | $746,000 | -31.7% | 53,789 | -5.0% | 0.02% | 0.0% |
| Q1 2022 | $1,092,000 | -37.6% | 56,601 | +16.8% | 0.02% | -37.1% |
| Q4 2021 | $1,750,000 | -18.6% | 48,458 | +23.7% | 0.04% | -12.5% |
| Q3 2021 | $2,151,000 | +12.5% | 39,185 | +38.2% | 0.04% | +29.0% |
| Q2 2021 | $1,912,000 | -19.5% | 28,345 | +6.0% | 0.03% | -26.2% |
| Q1 2021 | $2,374,000 | +32.3% | 26,744 | +21.8% | 0.04% | +7.7% |
| Q4 2020 | $1,795,000 | +10.0% | 21,949 | -38.6% | 0.04% | -25.0% |
| Q3 2020 | $1,632,000 | – | 35,722 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |